Masimo (MASI) announced that it has initiated legal action against Politan Capital Management amid an ongoing proxy battle for board membership. The company is seeking an injunction requiring Politan to correct material misstatements.MASI also announced a new date for its 2024 annual meeting of stockholders, now set for Sep 19, 2024. This change is aimed at ensuring a fair and fully informed vote by the shareholders. The meeting was initially scheduled for Jul 25.Reasons Behind the LitigationMasimo's lawsui ...

Joe Kiani, Founder, Chairman & CEO, Masimo; on Startup University Stage on day three of Collision 2024 at the Enercare Centre in Toronto, Canada.Proxy advisor Institutional Shareholder Services said boardroom change at medical technology company Masimo was "absolutely necessary" in a Monday report, and took particular aim at CEO Joe Kiani, of whom they said wanted to "have his cake and eat it" in running a publicly traded company as though it was a privately held one.The unusually sharp report, a copy of wh ...

文章核心观点 - 代理顾问公司Glass Lewis建议Masimo公司股东选举Politan提名的两名董事候选人Bill Jellison和Darlene Solomon [2] - Glass Lewis认为Masimo的现任董事未能有效监管公司,CEO Kiani过度主导公司运营 [3][6][7] - Politan正试图罢免创始人Kiani,但Kiani表示这将触发4亿美元的控制权变更补偿 [4] - Glass Lewis认为Masimo的公司治理存在问题,未能有效保护股东利益 [8] 根据目录分别总结 公司概况 - Masimo是一家医疗技术公司,以其Apple Watch专利诉讼而闻名 [2] - Masimo的董事会成员包括CEO Kiani、前迪士尼CEO Chapek以及Politan的管理合伙人Koffey [5] 公司治理问题 - Glass Lewis认为Kiani过度主导公司运营,董事会缺乏基本的问责制和有效监管 [6][7] - Masimo存在"极少责任"和"糟糕的公司治理"问题 [7] - Masimo未能解决"对股东价值的深重损害" [8] 代理投票建议 - Glass Lewis建议股东选举Politan提名的两名董事候选人 [2] - Glass Lewis对Masimo抨击Jellison和Solomon的"不太有说服力的努力"持批评态度 [10] 股东争议 - Politan指控Masimo一名接近Kiani的未具名股东可能违反SEC规定,增持股份至近10%后投票支持Kiani并抛售股票 [11] - 尽管Glass Lewis无法核实这一指控,但发现Masimo大股东RTW的公开持股比例与其私下告知Glass Lewis的9.9%持股比例存在差异,与Politan的担忧相符 [13] - RTW是Masimo的"长期可信伙伴",Kiani在RTW网站上有推荐性陈述 [14]

Masimo (MASI) recently announced that, on Jul 2, it received a non-binding term sheet confirmation from a third party, which included an acquisition offer for MASI’s consumer business. MASI did not provide any details about the third party.Masimo and the third party entered into a non-binding term sheet in May to sell the majority stake in MASI’s consumer audio and consumer health businesses. The third party offered to acquire a stake in MASI’s consumer business for a purchase price in the range of $850 mil ...

Masimo Corporation (MASI) announced preliminary financial results for second-quarter 2024 on Jul 9. Following this release, the company’s shares edged up 0.1% in the after-hours trading session.The company is expected to release second-quarter results on Aug 13, 2024.Prelim Q2 in DetailPer the preliminary release, second-quarter 2024 consolidated revenues are likely to be $496 million, up 9% year over year on a reported basis. The Zacks Consensus Estimate is pegged at $493.5 million.At constant exchange rat ...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, July 02, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Masimo Corporation ("Masimo" or the "Company") (NASDAQ: MASI) investors that a class action has been filed on behalf of investors. Masimo investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.c ...

Masimo Corporation (MASI) recently announced Sleep Halo, a powerful new feature, for its Masimo W1 Sport advanced health tracking wearable, intended for scientifically based sleep analysis. Sleep Halo is likely to offer overnight sleep data tracking with an unmatched 70,000+ daily measurements of second-by-second continuous health data. Existing Masimo W1 Sport owners will soon be able to update their watch firmware and Masimo Health app to begin their sleep-tracking journey with Sleep Halo. Masimo W1 Sport ...

NEW YORK, June 30, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Masimo and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On May 7, 2024, M ...

NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Masimo Corporation (NASDAQ: MASI) resulting from allegations that Masimo may have issued materially misleading business information to the investing public. So what: If you purchased Masimo securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The ...

Masimo Corporation (MASI) and Cleveland Clinic, a nonprofit academic medical center, recently announced their strategic collaboration to improve the standard of patient care while utilizing hospital-based remote patient monitoring (RPM), including TeleCritical Care. The partnership is intended to integrate Cleveland Clinic’s critical care and non-critical care central patient monitoring platforms with Masimo’s Hospital Automation platform. The partnership is likely to provide tools for clinicians that offer ...